Uveitis/Intraocular Inflammatory Disease Biobank (iBank) | MicrobiomeTrials← Back to trialsNCT02656381
Uveitis/Intraocular Inflammatory Disease Biobank (iBank)
CompletedOBSERVATIONAL
Trial Details
Start: 2016-07-26Est. Completion: 2023-05-04
Enrollment target: 343 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Crohn's Disease
This is a phase 2, multinational, multicenter, randomized, double-blind, placebo-controlled, dose ranging study to evalu…
Sun City, United StatesEst. completion Jul 30, 2026
Diabetic Retinopathy
Diabetic Retinopathy (DR) is a common eye condition caused by diabetes, where high blood sugar levels damage the blood v…
Phoenix, United StatesEst. completion Jun 2028
Recruiting
Uveitis, an inflammation inside the eye. Although rare, it is an important auto-inflammatory eye condition that affect c…
Sheffield, United KingdomEst. completion Feb 2027